Jan 28, 2026 07:08AM
Dec 29, 2025 04:47AM
Nov 5, 2025 07:27AM
Nov 5, 2025 07:00AM
Jul 30, 2025 07:06AM
Jul 30, 2025 07:00AM
Jul 9, 2025 07:15AM JPMorgan Reiterates Overweight Rating on Teva Pharma (TEVA)
Jun 6, 2025 01:16PM
May 7, 2025 07:30AM
May 7, 2025 07:03AM
Jan 29, 2025 07:03AM
Nov 6, 2024 08:31AM
Jul 31, 2024 11:46AM
Jul 31, 2024 11:45AM Medincell’s Partner Teva Provides Update on Pivotal Clinical Phase 3 of Investigational Olanzapine Long-Acting Injectable (LAI) and UZEDY® Commercial Progress
Jul 31, 2024 07:33AM
Jul 2, 2024 06:00PM
May 8, 2024 07:20AM
May 8, 2024 07:05AM
May 8, 2024 07:00AM
Apr 16, 2024 05:54PM
Apr 16, 2024 05:43PM Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
Apr 9, 2024 04:30PM
Feb 25, 2024 08:36PM
Feb 23, 2024 08:15PM
Jan 31, 2024 08:10AM
Jan 31, 2024 07:06AM
Jan 31, 2024 07:00AM
Jan 2, 2024 04:30PM Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance at 8 a.m. ET on January 31, 2024
Nov 8, 2023 07:42AM
Nov 8, 2023 07:10AM
Nov 8, 2023 07:00AM
Oct 6, 2023 04:30PM
Oct 4, 2023 05:42AM
Oct 4, 2023 01:07AM
Oct 2, 2023 01:55PM These 10 stocks are BofA's top ideas for Q4
Aug 3, 2023 04:05PM
Aug 2, 2023 07:07AM
Aug 2, 2023 07:00AM
Jul 5, 2023 04:30PM
May 10, 2023 07:04AM
May 10, 2023 07:00AM
Apr 14, 2023 04:15PM Teva to Host Conference Call to Discuss First Quarter 2023 Financial Results at 8 a.m. ET on May 10, 2023
Mar 6, 2023 04:05PM
Feb 27, 2023 08:00AM
Feb 8, 2023 07:09AM
Feb 8, 2023 07:00AM
Jan 12, 2023 04:30PM
Nov 22, 2022 08:31AM
Nov 22, 2022 08:30AM Teva Finalizes Nationwide Opioid Settlement Terms
Nov 10, 2022 09:00AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All